HealthEurope

Policy Spotlight

Strategies And Interventions To Improve CVD Prevention: Lessons Learned from Italy

Suggested interventions to reduce CVD burden in Italy (from (High Blood Pressure & Cardiovascular Prevent 2008; 15:63-73, and from (Atherosclerosis Supplements 2009; 10: 3-21)

Better Lipid-Lowering Therapy Improves Long-Term Financial Health Care Sustainability: A Simulation Model

From Atherosclerosis Supplements 2009; 10: 3-21.

Red Alert for Women’s Hearts

Recommendations to improve the awareness, diagnosis and treatment of Cardio Vascular Diseases in women.

Focus on Science

The Importance For Women Of Maintaining A Healthy Weight From Early Adulthood

Adiposity and weight change in mid life in relation to healthy survival after 70 in women: BMJ 2009; 339:b3796

Physician And Pharmacist Collaboration To Improve Blood Pressure Control

Studies have demonstrated that blood pressure control can be improved when clinical pharmacists assist with patient management.

Subclinical Atherosclerosis And Inflammatory Markers: The Influence On The Global CV Risk

There is great interest in identifying asymptomatic individuals at risk, who would be candidates for more intensive, evidence-based medical interventions aimed at preventing death and disability from coronary heart disease (CHD) and stroke.

HealthEurope.org!

The loss of life, disability, and economic burden attributed to non communicable disease (NCD) in Europe has created an urgent need for all stakeholders in NCD prevention to partner together to address the barriers in local health policy and produce effective programs in individual and population risk reduction and rational use of health services.

Hot Topics

Barriers to Cardio Vascular Disease Prevention

Numerous barriers to CVD prevention and management remain to be conquered, both in the individual patient and in the at-risk population as a whole.

Hypercholesterolemia And Cardio Vascular Diseases

Is the effective management of hypercholestelomia still an open question?

Cardiovascular Diseases Are Killing Every Year More Than 17.5 Million People Worldwide

They are the main cause of death and disability in Europe, accounting each year for more than 4.2 million deaths in the WHO European region, and more than 2 million deaths across the EU member states, and costing the EU economy an estimated €192 billion a year.

Further Lessons To Understand Better Statins And Cell-Dependent Effects In The Brain

Reports on the effectiveness of the use of statins in Alzheimer’s disease, though controversial, could encourage researchers to understand better the effects of statins on the brain, which are less well understood than their effects on other target organs, rather than justify a discontinuation of the research.